|
Search concepts
|
|
Selected Filters
|
- 1 - 25 out of 339 results
- Export search results
Face masks are essential to slowing the coronavirus spread. Here’s a guide to help you
6/15/20
2 items of Media coverage
Press/Media: Expert Comment
Searching for coronavirus clues in single cells
6/11/20
1 item of Media coverage
Press/Media: Expert Comment
COVID-19: Texas Virologist Discusses Where We Are and Where We're Headed
6/10/20
1 item of Media coverage
Press/Media: Expert Comment
University of Texas: Estrogen and Testosterone Therapies May Decrease Severity of COVID-19
Elena Volpi, Jacques Baillargeon & Randall Urban
6/10/20
1 item of Media coverage
Press/Media: Expert Comment
In Galveston County, COVID-19 reaches 1,000-case milestone
6/9/20
1 item of Media coverage
Press/Media: Expert Comment
Reminder - BioSig Subsidiary, ViralClear To Host Conference Call On June 9th To Discuss Upcoming And Recent Developments For Phase II Human Clinical Trials Of Its Broad-Spectrum Oral Anti-Viral Candidate For Treatment Of COVID-19
Slobodan Paessler, John Manning & Cheng Huang
6/8/20
11 items of Media coverage
Press/Media: Expert Comment
SORRENTO THERAPEUTICS : COVID TRAP Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection in Vitro
6/8/20
2 items of Media coverage
Press/Media: Expert Comment
Galveston County's top health official is OK being the 'prophet of doom'
6/6/20
1 item of Media coverage
Press/Media: Expert Comment
Sorrento COVIDTRAP(STI-4398) Demonstrates in Preclinical Studies its Ability to Completely Inhibit SARS-CoV-2 Viral Infection In Vitro
6/5/20
2 items of Media coverage
Press/Media: Expert Comment
Sorrento COVIDTRAP™(STI-4398) Demonstrates In Preclinical Studies Its Ability To Completely Inhibit SARS-CoV-2 Viral Infection In Vitro
6/5/20
28 items of Media coverage
Press/Media: Expert Comment
ViralClear Adds St. David's HealthCare In Austin, Texas, To Its Planned Phase II Trial For Its Broad-Spectrum Oral Anti-Viral Candidate For COVID-19
Slobodan Paessler, John Manning & Cheng Huang
6/5/20
25 items of Media coverage
Press/Media: Expert Comment
A Wuhan doctor says coronavirus is a U.S. weapon and explains why
6/4/20
1 item of Media coverage
Press/Media: Expert Comment
University of Texas Medical Branch Part of NIH-Funded Study of How COVID-19 Pandemic May Impact Pregnancy Outcomes
6/2/20
1 item of Media coverage
Press/Media: Expert Comment
UTMB part of NIH-funded study of how COVID-19 pandemic may impact pregnancy outcomes
6/2/20
1 item of Media coverage
Press/Media: Expert Comment
ViralClear To Host Conference Call On June 9th To Discuss Upcoming And Recent Developments For Phase II Human Clinical Trials Of Its Broad-Spectrum Oral Anti-viral Candidate For Treatment Of COVID-19
Slobodan Paessler, John Manning & Cheng Huang
6/1/20
14 items of Media coverage
Press/Media: Expert Comment
La Marque man recovering after 51 days in the hospital fighting COVID-19
5/27/20
1 item of Media coverage
Press/Media: Expert Comment
Local providers begin to offer COVID-19 antibody testing in Galveston County
5/26/20
1 item of Media coverage
Press/Media: Expert Comment
Doctors might already know which drugs can kill the coronavirus
5/23/20
2 items of Media coverage
Press/Media: Expert Comment
Health Doctors might already know which drugs can kill the coronavirus – BGR
5/23/20
1 item of Media coverage
Press/Media: Expert Comment
Atomwise Partners with Global Research Teams to Pursue Broad-Spectrum Treatments Against COVID-19 and Future Coronavirus Outbreaks
5/20/20 → 5/21/20
26 items of Media coverage
Press/Media: Expert Comment
BioLargo Subsidiary Clyra Medical’s Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study
5/19/20 → 5/21/20
5 items of Media coverage
Press/Media: Expert Comment
BioSig Technologies: ViralClear Closes $10.8 Million Equity Financing for Development of COVID-19 Broad-Spectrum Oral Anti-Viral Candidate Merimepodib
Slobodan Paessler, John Manning & Cheng Huang
5/20/20
1 item of Media coverage
Press/Media: Expert Comment